Related Experiment Video
Updated: Aug 8, 2026

Assessing Somatic Hypermutation in Ramos B Cells after Overexpression or Knockdown of Specific Genes
Published on: November 1, 2011
DNA modification induced by 6-mercaptopurine riboside in murine embryos
Abstract:
The cytostatic drug 6-mercaptopurine riboside (6-MPr) was investigated in mice in order to test the hypothesis that the teratogenicity of this antimetabolite is paralleled by an incorporation into the DNA of the embryos during organogenesis. DNA modification in the embryos was analysed 4 h following s.c. administration of [35S]-labelled 6-MPr to the dams on day 11 of pregnancy. The DNA of the embryos was isolated and hydrolysed to the bases by formic acid. Following separation by cation-exchange HPLC 6-thioguanine was found in the hydrolysate. Quantitation was performed by liquid scintillation counting. Evaluations of 6 doses in the range of 8-25 mg/kg were performed. An incorporation rate of 6-thioguanine from 32-56 pmol per mumol guanine was found in the DNA of the embryos. These findings suggest that, similar to the previously studied alkylating agents, the teratogenicity of 6-MPr may be, at least in part, induced via DNA modification of the embryos.
Insights
The antimetabolite 6-mercaptopurine riboside (6-MPr) was found to incorporate into embryonic DNA during pregnancy. This DNA modification may contribute to the teratogenicity of 6-MPr.
Area of Science:
- Developmental toxicology
- Pharmacology
- Molecular biology
Background:
- 6-mercaptopurine riboside (6-MPr) is a cytostatic antimetabolite.
- The teratogenic potential of 6-MPr requires further investigation.
- Understanding drug-induced developmental toxicity is crucial for risk assessment.
Purpose of the Study:
- To test the hypothesis that 6-MPr teratogenicity is linked to its incorporation into embryonic DNA.
- To investigate DNA modification in mouse embryos following maternal administration of 6-MPr.
Main Methods:
- Pregnant mice were administered [35S]-labelled 6-MPr on day 11 of gestation.
- Embryonic DNA was isolated and hydrolyzed to bases using formic acid.
- Cation-exchange HPLC and liquid scintillation counting were used to quantify 6-thioguanine incorporation.
Main Results:
- 6-thioguanine, a metabolite of 6-MPr, was detected in the DNA hydrolysate of embryos.
- Incorporation rates of 32-56 pmol 6-thioguanine per μmol guanine were quantified in embryonic DNA.
- Significant DNA modification was observed in embryos exposed to 6-MPr.
Conclusions:
- The findings suggest that 6-MPr can be incorporated into embryonic DNA during organogenesis.
- DNA modification by 6-MPr may be a mechanism underlying its teratogenicity.
- This mechanism is potentially similar to that of previously studied alkylating agents.
Related Concept Videos
In-vitro Mutagenesis
RNA Editing
Biosynthesis of Nucleic Acids

